Literature DB >> 22968881

Changes in direct-to-consumer pharmaceutical advertising following shifts from prescription-only to over-the-counter status.

Jeremy A Greene1, Niteesh K Choudhry, Aaron S Kesselheim, Troyen A Brennan, William Shrank.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22968881     DOI： 10.1001/2012.jama.10647

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs.

Authors:  Adrienne E Faerber; David H Kreling
Journal:  J Gen Intern Med       Date:  2014-01       Impact factor: 5.128

2.  Communicating Risk Information in Direct-to-Consumer Prescription Drug Television Ads: A Content Analysis.

Authors:  Helen W Sullivan; Kathryn J Aikin; Jon Poehlman
Journal:  Health Commun       Date:  2017-11-10

3.  Consumer perceptions of prescription and over-the-counter drug advertisements with promotional offers.

Authors:  Kathryn J Aikin; Helen W Sullivan; Amie C O'Donoghue; Kevin R Betts
Journal:  Health Mark Q       Date:  2016-10-19

Review 4.  Prescription to over-the-counter switches in the United States.

Authors:  Jongwha Chang; Allison Lizer; Isha Patel; Deepak Bhatia; Xi Tan; Rajesh Balkrishnan
Journal:  J Res Pharm Pract       Date:  2016 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.